A Review of the Effect of COVID-19-Related Lockdowns on Global Cancer Screening
- PMID: 37448422
- PMCID: PMC10336183
- DOI: 10.7759/cureus.40268
A Review of the Effect of COVID-19-Related Lockdowns on Global Cancer Screening
Abstract
COVID-19 lockdowns have led to significant disruptions in preventative health services worldwide. This review aims to assess the impact of COVID-19 lockdowns on worldwide preventive cancer screening participation. Major medical databases were searched using the keywords 'lockdown,' 'cancer,' and 'screening or diagnosis,' and relevant articles were evaluated against inclusion and exclusion criteria. The final review consisted of 38 studies. The impact of COVID-19 on screening uptake was categorized based on cancer type. All types of screening had decreased participation during or around the lockdown period. Racial and socioeconomic disparities, provider-related barriers, and patient attitudes about service disruptions during the pandemic were also highlighted in this review. Future research should focus on data from low- and middle-income countries to obtain a more comprehensive picture of the problem. Policy interventions that adopt self-screening or different screening intervals can also be considered to reduce impacts in future crises. Insights from existing studies and future research will allow for more proactive measures to manage future disruptions.
Keywords: covid 19; covid 19 impact of lockdown; covid-19 and cancer screening; covid-19 lockdown; global oncology; preventive oncology; public health care; public health policies.
Copyright © 2023, Bharwani et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Cancer. [ Nov; 2022 ];https://www.who.int/news-room/fact-sheets/detail/cancer 2022 17:2022.
-
- Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. Kocarnik JM, Compton K, Dean FE, et al. JAMA Oncol. 2022;8:420–444. - PMC - PubMed
-
- Incidence and relative survival by stage at diagnosis for common cancers. [ Nov; 2022 ]. 2021. http://www.cdc.gov/cancer/uscs/about/data-briefs/no25-incidence-relative... http://www.cdc.gov/cancer/uscs/about/data-briefs/no25-incidence-relative...
-
- Cancer prevention and early detection facts & figures 2019-2020. [ Oct; 2022 ]. 2019. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-... https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-...
-
- Screening for cancer: the economic, medical, and psychosocial issues. Brill JV. Am J Manag Care. 2020;26:0–6. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources